Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Mobocertinib for locally advanced or metastatic NSCLC	TAK-788 (AP32788; Mobocertinib)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2021	View \| Download
Momelotinib for the treatment of symptomatic and anaemic myelofibrosis	Momelotinib	Anaemic myelofibrosis	Haematological Cancer and Lymphomas , Haematology	2022	View \| Download
Mosunetuzumab (subcutaneous injection) for treating relapsed or refractory follicular lymphoma	Mosunetuzumab (BTCT4465A)	Follicular lymphoma	Haematological Cancer and Lymphomas	2024	View \| Download
Mosunetuzumab for relapsed or refractory B-cell follicular lymphoma – third-line and greater	Mosunetuzumab (BTCT4465A)	Follicular lymphoma	Haematological Cancer and Lymphomas	2021	View \| Download
MTX-110 for newly-diagnosed diffuse intrinsic pontine glioma	Panobinostat (MTX-110; Farydak; LBH589; LBH-589; panobinostat lactate anhydrous)	Glioma	Neurological Cancer	2019	View \| Download
Nab-paclitaxel in Combination with Gemcitabine for Resected Pancreatic Ductal Adenocarcinoma - Adjuvant Therapy	Gemcitabine (Gemzar; gemcitabine hydrochloride) , Nab-Paclitaxel (Abraxane; ABI 007; ABI-007)	Pancreatic cancer	Gastrointestinal Cancer	2017	View \| Download
Naloxone Auto-injector (Evzio) for Opioid Substance Use Disorder	Naloxone hydrochloride (Evzio; Narcan; OPNT001; Nalscue; Nalcol; E-0316)	Opioid overdose	Toxicology	2018	View \| Download
Natalizumab (subcutaneous injection) for highly active relapsing remitting multiple sclerosis	Natalizumab (BG00002; Tysabri; Antegren; AN-100226; ELND-002)	Multiple sclerosis (MS)	Neurology	2021	View \| Download
Natalizumab biosimilar for treating relapsing-remitting multiple sclerosis	Natalizumab biosimilar (PB006)	Multiple sclerosis (MS)	Neurology	2022	View \| Download
Navitoclax with ruxolitinib for myelofibrosis	Navitoclax (ABT 263, ABT-263) , Ruxolitinib (Jakavi; INCB018424; CTP-543; ruxolitinib phosphate)	Myelofibrosis	Haematological Cancer and Lymphomas	2022	View \| Download